Orbimed Advisors LLC filed its 13F report for Q4 2025 on February 17, 2026. The portfolio totaled 4.9 B reflecting a +15.13% change from the prior quarter, spanning 107 assets. The top 10 holdings comprised 40.7% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 23 new positions and 17 complete exits.
Items:
Total Value:
| Issuer Name | Class | Value | Shares | Option Type |
|---|
Orbimed Advisors submitted their Form 13F-HR for the Q4 2025 period on 02/17/2026. This was the only submission for the quarter.
In the Q4 2025 filing, Orbimed Advisors reported a managed portfolio value of 4.9 B, consisting of 108 individual positions.
This page displays the raw filing documents. To see which stocks Orbimed Advisors bought or sold during Q4 2025, please visit Orbimed Advisors's Portfolio Analysis page.